Search

Search Constraints

You searched for: Author/Creator Notohara Kenji investigator.

Search Results

1. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4‐sclerosing cholangitis: Based on a Japanese nationwide study. Issue 4 (10th January 2023)

2. Steroid therapy still plays a crucial role and could serve as a bridge to the next promising treatments in patients with IgG4‐related sclerosing cholangitis: Results of a Japanese nationwide study. (25th May 2022)

3. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease. Issue 1 (2nd December 2019)